Pneumococcal Necrotizing Pneumonia and Pleural Fluid Lactate Dehydrogenase Level
To the Editor-I read with interest the recent article by Bender et al. [1] about pneumococcal necrotizing pneumonia (NP) in children. The results of the study confirm the severity of this entity in children (as reported elsewhere [2] [3] [4] ), and the study enhances the previous findings with more detailed serotype analysis. Similar to the findings of Bender et al. [1] , we have recently seen at our institution severe presentations and bad outcomes of pneumococcal NP associated with serotype 3 and other serotypes [5, 6] . Of concern to us, very high initial lactate dehydrogenase (LDH) levels were seen in pleural fluid specimens obtained from children who received an initial diagnosis of pneumococcal empyema and who subsequently developed severe NP and required extensive decortications, segmentectomies, or lobectomies. In retrospect, some of these children eventually would have benefited from earlier surgical interventions.
Although children with complicated pneumococcal pneumonia who require decortication drainage may have higher levels of LDH in pleural fluid [7] , it is uncertain whether patients with pneumococcal NP exhibit significantly higher LDH levels in pleural fluid, compared with patients with NP due to Staphylococcus aureus or other organisms. In the 2 largest series of NP in children, an in-depth analysis of this issue was not performed [8, 9] . Similarly, studies comparing pleural fluid LDH levels in children with complicated pneumococcal pneumonia caused by non-pneumococcal conjugate vaccine-7 serotypes versus pneumococcal conjugate vaccine-7 serotypes have not been performed.
LDH, a useful parameter in pleural fluid analysis for patients with complicated pneumonia (among others), reflects cellular injury and can be released by cells undergoing either primary or secondary necrosis. Recent research findings in mice have revealed that, during severe pulmonary inflammation (i.e., bacterial pneumonia), apoptotic neutrophils undergoing secondary necrosis are the primary source of LDH in bronchoalveolar lavage fluid [10] . The clinical relevance of these findings is unknown for children with complicated pneumonia; however, it is likely that these changes also occur in the lungs of individuals with NP, which may partially explain the elevated LDH levels seen in these individuals. These high or abnormally high values should alert clinicians about the possibility of ongoing necrosis or liquefaction of the pulmonary parenchyma, and clinicians must give special attention to this issue in the present era, in which NP is more commonly reported.
The study by Bender et al. [1] is admirable, and I understand that the objectives that they intended at the beginning were different from the issues that I discuss here. However, considering that their study involved children with necrotizing pneumonia, mention of other aspects of this entity is important and would benefit their study. At the suggestion of Ulloa-Gutierrez [1], we retrospectively evaluated the pleural fluid LDH levels in the 14 patients with serotype 3 pneumonia in our study. Five of the 14 patients had pleural fluid LDH levels measured. The median LDH level was 49,460 U/L (range, 39,700-118,041 U/ L). These values represent a 40-120-fold increase over the upper limit of normal for serum LDH level in our laboratory (975 U/L). These findings appear to be consistent with those of Ulloa-Gutierrez [1] . However, care should be taken when comparing pleural fluid indices from retrospective studies because of the variability in time to presentation and other clinical and laboratory factors.
Complicated pneumonia in children is a growing problem worldwide. We agree with Ulloa-Gutierrez [1] that pleural fluid indices might prove to be a useful adjunct in predicting outcomes and directing management. In a separate study, we demonstrated that among children with empyema, those with pleural fluid indices including higher WBC counts, lower glucose values, and the presence of bacteria on Gram stain or culture were more likely to require surgical intervention than were those without these findings [3] . The degree of LDH elevation, however, was not associated with the need for surgical intervention.
Natural Products and Wound Management: A Never-Ending Story
To the Editor-Kwakman et al. [1] evaluated the efficacy of Revamil medicalgrade honey as a topical antimicrobial agent for prevention or treatment of infection, including those caused by multidrug-resistant bacteria, and they proposed this natural product for the treatment of wound infections. Their article raises some questions about the use of natural products in modern medicine and about what can be learned from the medical practices of ancient centuries [1] .
In some ways, the history of medicine is strictly bound to the care of wounds, especially those injuries caused in battles. In Mesopotamia (2100 bc), after cleaning a wound with beer, a bandage with wine and turpentine was applied. In Ancient Egypt, a natural product, such as honey, became common in wound management: after irrigating a wound with wine, physicians would then cover the wound with fat and honey. In Greece, during the time of Homer, wounds were covered and treated with herbs, whereas infected wounds were healed by dropping scrapings from bronze spears into them.
Four hundred years later, Hippocrates taught that wounds should be washed with wine, bandaged, and then saturated with more wine. Galen, of ancient Rome, cleaned wounds with vinegar but nevertheless believed that suppuration ("pus bonum et laudabile") was necessary for healing. This belief prevailed for many centuries.
When gunpowder was first used in battle, boiling oil was used as wound treatment, with the aim "to inactivate" the gunpowder effect within gunshot wounds.
